View in EDS HTML Full Text PDF Full Text

Correction: Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma.

Saved in:
Bibliographic Details
Title: Correction: Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma.
Authors: Suzuki, Shinsuke1,2,3 (AUTHOR), Lin, Xiao-Yan4 (AUTHOR), Hanada, Shuichi5 (AUTHOR) hanadas1949@icloud.com, Uozumi, Kimiharu6 (AUTHOR), Otsuka, Maki5 (AUTHOR), Owatari, Satsuki5 (AUTHOR), Haraguchi, Koichi5 (AUTHOR), Yoshimitsu, Makoto3 (AUTHOR), Ishitsuka, Kenji3 (AUTHOR), Takahashi, Hiroshi7 (AUTHOR)
Source: Scientific Reports. 10/1/2025, Vol. 15 Issue 1, p1-3. 3p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-21843-4